Positive results for Buvidal® in treatment for fentanyl dependence
New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl abuse, among other things, compared to other standard treatments as well as lower withdrawal and drug craving.
New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl abuse, among other things, compared to other standard treatments as well as lower withdrawal and drug craving.
Read more at Camurus’ website: https://www.camurus.com/pressreleases/
Latest news
2020-12-14
Camurus announces outcome of the arbitration process with Braeburn.
Camurus announced on December 10, 2020, that the ICC International Court of Arbitration has issued a partial award i…